Trial Outcomes & Findings for Risk Factors for Implant Bone Loss in Patients With Diabetes Mellitus (NCT NCT00933491)

NCT ID: NCT00933491

Last Updated: 2015-11-04

Results Overview

Mean radiographic bone level at 12 months

Recruitment status

COMPLETED

Target enrollment

32 participants

Primary outcome timeframe

12 months

Results posted on

2015-11-04

Participant Flow

Participant milestones

Participant milestones
Measure
Diabetic
Type II Diabetes
Control
Non-diabetics
Overall Study
STARTED
14
18
Overall Study
COMPLETED
14
18
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Risk Factors for Implant Bone Loss in Patients With Diabetes Mellitus

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Diabetic
n=14 Participants
Type II Diabetes
Control
n=18 Participants
Non-diabetics
Total
n=32 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
14 Participants
n=5 Participants
18 Participants
n=7 Participants
32 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
65 years
n=5 Participants
64 years
n=7 Participants
64.5 years
n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
9 Participants
n=7 Participants
16 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
9 Participants
n=7 Participants
16 Participants
n=5 Participants
Region of Enrollment
United States
14 participants
n=5 Participants
18 participants
n=7 Participants
32 participants
n=5 Participants

PRIMARY outcome

Timeframe: 12 months

Mean radiographic bone level at 12 months

Outcome measures

Outcome measures
Measure
Diabetic
n=14 Participants
Type II Diabetes
Control
n=18 Participants
Non-diabetics
Radiographic Bone Level
2.69 mm
Standard Deviation .17
2.54 mm
Standard Deviation .15

PRIMARY outcome

Timeframe: Baseline

Mean radiographic bone level at baseline

Outcome measures

Outcome measures
Measure
Diabetic
n=14 Participants
Type II Diabetes
Control
n=18 Participants
Non-diabetics
Radiographic Bone Level
2.59 mm
Standard Deviation .15
2.71 mm
Standard Deviation .14

Adverse Events

Diabetic

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Tae-Ju Oh

University of Michigan

Phone: 734-647-3320

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place